Clinical trial

ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia

NCT01717911

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Insulin Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sitagliptin Normalized identity: sitagliptinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-09-01

PhasePHASE4

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

InsulinDRUG

MetforminDRUG · verified · RxNorm: metformin

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

Taipei Veterans General Hospital, Taiwanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01717911 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.